Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Biosimilars V 2.0

Biosimilars: SOP for Risk Assessment in Upstream Failures – V 2.0

Posted on By

To establish a structured approach for performing risk assessment in the event of upstream processing failures during biosimilar manufacturing, ensuring timely identification of root causes, impact analysis, and implementation of corrective and preventive actions (CAPA).
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Temperature Excursions During Fermentation – V 2.0

Posted on By

To outline the procedure for detecting, documenting, investigating, and responding to temperature excursions during fermentation processes in biosimilar manufacturing, ensuring product quality and regulatory compliance.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Shift Handover Procedures – V 2.0

Posted on By

To define the procedure for effective shift handover between outgoing and incoming personnel in biosimilar manufacturing areas to ensure accurate communication, task continuity, and compliance with GMP practices.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Material Traceability in Upstream – V 2.0

Posted on By

To define a standard procedure for ensuring complete traceability of all materials used in upstream processes during biosimilar manufacturing, from raw material receipt to final usage, in compliance with GMP guidelines.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Chromatography Column Cleaning Before Reuse – V 2.0

Posted on By

To establish a validated procedure for cleaning chromatography columns used in biosimilar purification prior to reuse, in order to remove residual product, prevent cross-contamination, and maintain resin performance as per GMP and manufacturer’s guidelines.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Buffer Preparation for Harvest Operations – V 2.0

Posted on By

To define the procedure for the preparation, filtration, labeling, storage, and documentation of buffers used during harvest operations in biosimilar downstream processing to ensure product quality and GMP compliance.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Back-Up Seed Train Planning – V 2.0

Posted on By

To define the strategy and procedure for planning, preparing, and maintaining back-up seed trains in biosimilar upstream processes to mitigate risk of primary seed train failure and ensure batch continuity.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Cleaning Validation of Single-Use Systems – V 2.0

Posted on By

To define the validation strategy and procedure for ensuring cleaning effectiveness of single-use systems (SUS) in biosimilar manufacturing operations and to confirm the absence of cross-contamination risks, extractables, and leachables post-rinsing and usage.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Gowning Procedure for Upstream Suite – V 2.0

Posted on By

To establish a standardized gowning procedure for personnel accessing upstream manufacturing areas to minimize contamination risks and maintain aseptic and controlled conditions as per GMP guidelines.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Biosensor Integration and Verification – V 2.0

Posted on By

To define the standardized process for integrating biosensors into upstream bioreactors and conducting routine verification and calibration to ensure accurate, real-time process monitoring in biosimilar manufacturing operations.
Click to read the full article.

Biosimilars V 2.0

Posts pagination

Previous 1 … 13 14 15 … 20 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme